Synonyms : | none | ||||||||||||||||
Description : | IL-12 is a disulfide-linked heterodimeric protein (p70), composed of two subunits, p35 and p40, which are encoded by two different genes. Accumulating data indicate that p40 secretion precedes that of IL-12 expression. In addition, to its ability to covalently bind to p35 to form IL-12, p40 can bind to p19 to form IL-23, or can form a homodimer designated as IL-12 p80. Elevated levels of IL-12 p80 are correlated with macrophage recruitment and increased inflammation in asthma and respiratory viral infection models. Recombinant murine IL-12 p80 is an 80.0 kDa disulfide linked homodimer consisting of two p40 chains of IL-12. | ||||||||||||||||
Catalog #: | 210-12p80 | ||||||||||||||||
Source : | CHO cellls | ||||||||||||||||
Stability : | The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted IL-12 p80 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles | ||||||||||||||||
Purity : | Greater than 98% by SDS-PAGE gel and HPLC analyses. | ||||||||||||||||
Endotoxin Level : | Endotoxin level is less than 0.1 ng per μg (1EU/μg). | ||||||||||||||||
Biological Activity : | Not Available. | ||||||||||||||||
AA Sequence : | p40 Monomer: MWELEKDVYV VEVDWTPDAP GETVNLTCDT PEEDDITWTS DQRHGVIGSG KTLTITVKEF LDAGQYTCHK GGETLSHSHL LLHKKENGIW STEILKNFKN KTFLKCEAPN YSGRFTCSWL VQRNMDLKFN IKSSSSSPDS RAVTCGMASL SAEKVTLDQR DYEKYSVSCQ EDVTCPTAEE TLPIELALEA RNKYENYS TSFFIRDIIK PDPPKNLQMK PLKNSQVEVS WEYPDSWSTP HSYFSLKFFV RIQRKKEKMK ETEEGCNQKG AFLVEKTSTE VQCKGGNVCV QAQDRYYNSS CSKWACVPCR VRS | ||||||||||||||||
PubMed Link : | IL-12+AND+p80+AND+mouse | ||||||||||||||||
Country of Origin : | USA | ||||||||||||||||
|
|
相關產品
免責聲明
- 凡本網注明“來源:化工儀器網”的所有作品,均為浙江興旺寶明通網絡有限公司-化工儀器網合法擁有版權或有權使用的作品,未經本網授權不得轉載、摘編或利用其它方式使用上述作品。已經本網授權使用作品的,應在授權范圍內使用,并注明“來源:化工儀器網”。違反上述聲明者,本網將追究其相關法律責任。
- 本網轉載并注明自其他來源(非化工儀器網)的作品,目的在于傳遞更多信息,并不代表本網贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時,必須保留本網注明的作品第一來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發表之日起一周內與本網聯系,否則視為放棄相關權利。